Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

TheraCea Pharma LC
Profile last edited on: 8/11/21      CAGE: 89EB8      UEI: KSNLTEALRQL5

Business Identifier: Improving 18F-labeling of biologics
Year Founded
2019
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

6196 North Corte San Bella
Tucson, AZ 85741
   N/A
   N/A
   N/A
Location: Single
Congr. District: 02
County: 

Public Profile

Principals of the firm described TheraCea Pharma's focus as the development of novel chemical processes to enable efficient and quick 18F-labeling of biologics - having suggested relevance and application in immuno-oncology, neurological disorders, and infectious diseases.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$560,396
Phase II Dollars
$0
Total Awarded
$560,396

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NSF $256,000
Project Title: Developing Bioconjugation and Preparation of 18F-Biomolecules for PET Imaging
2020 1 NIH $304,396
Project Title: Developing Versatile and Facile Chemical Synthesis Methodologies for Preparation of 18f-Tracers for Pet Imaging

Key People / Management

  Iman Daryaei -- Chief Executive Officer, Chief Scientific Officer, and Co-Founder

  Lars R Furenlid

  Justin Jeffery -- Chief Business Officer, Co-Founder

Company News

There are no news available.